Viewing StudyNCT01185366

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 10:46 PM
Last Modification Date: 2024-10-26 @ 10:24 AM
Study NCT ID: NCT01185366
Status: TERMINATED
Last Update Posted: 2021-04-28
First Post: 2010-08-18
Brief Title: Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Kidney Cancer
Keywords:
Name View
ESPN View
Advanced non-clear cell renal cell cancer RCC View
Clear-cell renal cell carcinoma View
Collecting duct carcinoma View
Translocation carcinoma View
Chromophobe View
Everolimus View
Sunitinib View
Afinitor View
RAD001 View
Sunitinib Malate View
SUO11248 View
Sutent View